Skip to main content
NVDA+0.02%AAPL+0.11%GOOGL-3.15%MSFT-0.05%AMZN+0.11%TSM-4.52%SPCX-9.14%META-0.55%AVGO-4.31%TSLA-0.45%LLY+2.83%BRK-B+1.50%MU-1.37%WMT+2.82%SKHY-8.07%JPM+0.40%AMD-8.10%V+1.59%XOM+0.08%JNJ+3.81%ASMLa-4.74%MA+1.70%ABBV+0.03%INTC-8.04%COST+1.99%CVX-0.04%0700.HK+1.39%1398.HK-1.39%CSCO-2.21%KO+2.87%PG+5.58%UNH+1.91%ORCL-2.80%BAC+0.59%1816.HK-27.81%3988.HK-0.38%HD+4.33%CAT-4.89%0005.HK-0.38%PM+2.17%HSBA.L-2.45%0857.HK-0.52%GE-0.79%0939.HK+0.59%AP2d-6.79%1288.HK-1.60%AMAT-8.16%NVS+1.52%MS-1.63%LRCX-11.76%EURAUD-1.27%EURCAD-1.15%AUDUSD+1.04%EURNZD-0.93%USDCAD-0.91%USDTHB+0.87%EURJPY-0.81%AUDCHF+0.81%NZDUSD+0.71%EURGBP-0.70%CADCHF+0.69%USDJPY-0.61%GBPAUD-0.57%AUDJPY+0.48%NZDCHF+0.47%GBPUSD+0.47%GBPCAD-0.46%EURCHF-0.45%USDTRY+0.43%GBPTRY+0.41%CHFJPY-0.40%AUDNZD+0.34%CADJPY+0.33%GBPHKD+0.32%GBPMXN-0.28%CHFNOK-0.28%GBPNZD-0.26%NOKJPY+0.25%USDCHF-0.23%EURUSD-0.23%GBPCHF+0.23%NZDSGD+0.22%USDCNH-0.21%NZDCAD-0.20%CHFSEK-0.17%USDILS+0.16%CHFSGD-0.15%AUDCAD+0.13%GBPJPY-0.13%SGDJPY+0.13%NZDMXN+0.12%USDPLN+0.11%USDHKD-0.11%NZDJPY+0.10%EURNOK-0.09%EURPLN+0.09%AUDNOK-0.09%USDNOK-0.07%PLNJPY+0.06%USDSGD+0.05%USDZAR+0.05%USDMXN-0.04%USDSEK+0.04%USDCOP-0.04%AUDSGD+0.04%EURZAR+0.04%EURCZK+0.03%EURSGD+0.03%EURCNH-0.03%USDDKK+0.03%EURSEK+0.02%EURHKD+0.01%AUDDKK+0.01%GBPZAR-0.01%GBPSGD-0.01%EURDKK0.00%USOIL+1.74%UKOIL+1.26%HG1+0.96%XAGUSD-0.95%GAGUSD-0.95%XNGUSD-0.58%XPTUSD+0.35%W1+0.32%GAUUSD-0.27%XAUUSD-0.27%COTTON+0.22%S1+0.21%BTCUSD-2.64%ETHUSD+16.36%USDTUSD-0.07%XRPUSD+9.91%SOLUSD+10.75%TRXUSDT-0.20%ZECUSDT-6.67%DOGEUSD+14.39%XMRUSDT-1.83%LINKUSD+14.52%XLMUSD-2.96%BCHUSDT-0.14%UNIUSD-3.10%LTCUSD+8.69%SUIUSD-2.78%HBARUSDT-3.99%TONUSD+26.39%TAOUSDT-3.28%AAVEUSD-3.39%DOTUSDT+2.99%ICPUSDT-3.83%WLDUSDT-4.98%ONDOUSDT-4.82%ARBUSDT-2.92%JUPUSDT-4.25%ATOMUSDT+2.85%INJUSDT-4.97%STXUSDT-10.30%TIAUSDT-6.90%FETUSDT-3.24%PYTHUSDT-7.69%SEIUSDT-6.05%IMXUSDT-5.35%GRTUSDT-2.92%OPUSDT-7.20%WIFUSDT-4.14%IOTAUSDT-3.00%AXSUSDT-3.56%POLUSDT-2.93%FARTCOINUSDT-2.12%EOSUSDT-1.08%DYDXUSDT-3.44%GALAUSDT-2.52%ORDIUSDT-0.96%RONINUSDT-1.83%NOTUSDT-2.47%NVDA+0.02%AAPL+0.11%GOOGL-3.15%MSFT-0.05%AMZN+0.11%TSM-4.52%SPCX-9.14%META-0.55%AVGO-4.31%TSLA-0.45%LLY+2.83%BRK-B+1.50%MU-1.37%WMT+2.82%SKHY-8.07%JPM+0.40%AMD-8.10%V+1.59%XOM+0.08%JNJ+3.81%ASMLa-4.74%MA+1.70%ABBV+0.03%INTC-8.04%COST+1.99%CVX-0.04%0700.HK+1.39%1398.HK-1.39%CSCO-2.21%KO+2.87%PG+5.58%UNH+1.91%ORCL-2.80%BAC+0.59%1816.HK-27.81%3988.HK-0.38%HD+4.33%CAT-4.89%0005.HK-0.38%PM+2.17%HSBA.L-2.45%0857.HK-0.52%GE-0.79%0939.HK+0.59%AP2d-6.79%1288.HK-1.60%AMAT-8.16%NVS+1.52%MS-1.63%LRCX-11.76%EURAUD-1.27%EURCAD-1.15%AUDUSD+1.04%EURNZD-0.93%USDCAD-0.91%USDTHB+0.87%EURJPY-0.81%AUDCHF+0.81%NZDUSD+0.71%EURGBP-0.70%CADCHF+0.69%USDJPY-0.61%GBPAUD-0.57%AUDJPY+0.48%NZDCHF+0.47%GBPUSD+0.47%GBPCAD-0.46%EURCHF-0.45%USDTRY+0.43%GBPTRY+0.41%CHFJPY-0.40%AUDNZD+0.34%CADJPY+0.33%GBPHKD+0.32%GBPMXN-0.28%CHFNOK-0.28%GBPNZD-0.26%NOKJPY+0.25%USDCHF-0.23%EURUSD-0.23%GBPCHF+0.23%NZDSGD+0.22%USDCNH-0.21%NZDCAD-0.20%CHFSEK-0.17%USDILS+0.16%CHFSGD-0.15%AUDCAD+0.13%GBPJPY-0.13%SGDJPY+0.13%NZDMXN+0.12%USDPLN+0.11%USDHKD-0.11%NZDJPY+0.10%EURNOK-0.09%EURPLN+0.09%AUDNOK-0.09%USDNOK-0.07%PLNJPY+0.06%USDSGD+0.05%USDZAR+0.05%USDMXN-0.04%USDSEK+0.04%USDCOP-0.04%AUDSGD+0.04%EURZAR+0.04%EURCZK+0.03%EURSGD+0.03%EURCNH-0.03%USDDKK+0.03%EURSEK+0.02%EURHKD+0.01%AUDDKK+0.01%GBPZAR-0.01%GBPSGD-0.01%EURDKK0.00%USOIL+1.74%UKOIL+1.26%HG1+0.96%XAGUSD-0.95%GAGUSD-0.95%XNGUSD-0.58%XPTUSD+0.35%W1+0.32%GAUUSD-0.27%XAUUSD-0.27%COTTON+0.22%S1+0.21%BTCUSD-2.64%ETHUSD+16.36%USDTUSD-0.07%XRPUSD+9.91%SOLUSD+10.75%TRXUSDT-0.20%ZECUSDT-6.67%DOGEUSD+14.39%XMRUSDT-1.83%LINKUSD+14.52%XLMUSD-2.96%BCHUSDT-0.14%UNIUSD-3.10%LTCUSD+8.69%SUIUSD-2.78%HBARUSDT-3.99%TONUSD+26.39%TAOUSDT-3.28%AAVEUSD-3.39%DOTUSDT+2.99%ICPUSDT-3.83%WLDUSDT-4.98%ONDOUSDT-4.82%ARBUSDT-2.92%JUPUSDT-4.25%ATOMUSDT+2.85%INJUSDT-4.97%STXUSDT-10.30%TIAUSDT-6.90%FETUSDT-3.24%PYTHUSDT-7.69%SEIUSDT-6.05%IMXUSDT-5.35%GRTUSDT-2.92%OPUSDT-7.20%WIFUSDT-4.14%IOTAUSDT-3.00%AXSUSDT-3.56%POLUSDT-2.93%FARTCOINUSDT-2.12%EOSUSDT-1.08%DYDXUSDT-3.44%GALAUSDT-2.52%ORDIUSDT-0.96%RONINUSDT-1.83%NOTUSDT-2.47%
DT

Dyne Therapeutics, Inc. (DYN)

NASDAQ • Healthcare

$15.77
-$0.3 (-1.9%)
Market closed

Last close at October 22, 2026 at 20:00 UTC

Open$15.99
Day Range$15.67 - $16.34
Avg. Volume (3M)3.1M
Market Cap$2.9B
52 Week Range
$14$27.31
Next EarningsIn 12 daysNov 4, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$519.4M
EPS (TTM)
-$3.33
ROA (TTM)
-52.25%
Current Ratio
12.02

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-2.7%Q1 2026-$0.76
+5.5%Q2 2026-$0.73
-44.2%Q3 2026-$1.08
Next

Nov 4

in 12 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -44.2%

Dyne Therapeutics’ preliminary results for the second fiscal quarter of 2026, reported July 30, 2026, showed EPS trailing consensus, with EPS of -$1.08 below the -$0.75 estimate by -$0.33. The company posted a GAAP net loss of roughly $178.6 million, deepening by 61.1% year over year from about $110.9 million a year ago, alongside operating loss of about $181.7 million as it continued investing in its muscle-disease therapeutic development programs. Operating cash flow was negative roughly $130.3 million for the quarter, reflecting cash use during ongoing R&D and pipeline execution. On a per-share basis, EPS was down 11.3% year over year from -$0.97. Consensus for the next period calls for EPS of -$0.84.

Next report — what to expect

Dyne Therapeutics, Inc. (DYN) reports next on November 4, 2026. Wall Street is looking for consensus EPS of -$0.912. Historically, Dyne has beaten EPS in 4 of its 8 most recent quarters, making the EPS line a key focus heading into the print.

View full earnings history

About Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. is a NASDAQ-listed biotechnology company developing therapeutics for muscle disease. The company focuses on genetically driven disorders and operates as a small-cap healthcare developer, with its programs centered on disease-modifying approaches for serious rare conditions rather than commercialized products.

Name
Dyne Therapeutics, Inc.
CEO
John G. Cox
Website
www.dyne-tx.com
Industry
Healthcare
Year Founded
2017
Employees
289

Today's Snapshot

AI-generated

DYN closed 1.9% lower at 15.77, against a firmer sector. DYN reports earnings on 4 November.

Trading Volume

Below 10d avg (2.7M)

2M

vs S&P 500 Today

Underperforming Market

-0.61%

Updated: October 22, 2026 at 20:19 UTC

Technical Indicators

1 Buy3 Neutral4 Sell
DYN shows a down‑leaning bias driven by a strong ADX near 42 that points to a dominant trend, even as short-term averages sit at or just below the price. Momentum readings are mildly negative and MACD is marginally bearish, while the stock remains below longer-term 200-day averages, which retains longer-term pressure. Volatility is noticeable with an ATR near 6%, yet on‑balance volume is positive, offering a partial divergence between price weakness and cumulative flows. Technical takeaway: overall sell, driven by a strong trend and weakness versus long-term averages despite supporting volume.
All signals
  • EMA (5 indicators)$15.69 - $19.61
    Sell
  • RSI (14)42.42
    Neutral
  • Stochastic %K (14, 3, 3)59.96
    Neutral
  • MACD Level (12, 26)-0.95
    Neutral

Peers & Related Assets

IONSIonis Pharmaceuticals, Inc.
$43.91-0.8%
PTCTPTC Therapeutics, Inc.
$63.04+0.7%
SRPTSarepta Therapeutics, Inc.
$18.18-2.0%
STOKStoke Therapeutics, Inc.
$25.7+0.1%
SLDBSolid Biosciences Inc.
$6.19-3.4%
WVEWave Life Sciences Ltd.
$3.35-0.6%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.